Clinical Trial Update: Ribavirin for Hemorrhagic Fever With Renal Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of ribavirin for hemorrhagic fever with renal syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Fever with Renal Syndrome

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Hemorrhagic Fever With Renal Syndrome | Phase 2 | Status: WITHDRAWN